Effect of Shifting from Combination Therapy to Monotherapy of α-Blockers or 5α-Reductase Inhibitors on Prostate Volume and Symptoms in Patients with Benign Prostatic Hyperplasia

PURPOSE: Combination therapy of α-blockers and 5α-reductase inhibitors (5-ARIs) is widely used for the treatment of benign prostatic hyperplasia (BPH). We aimed to study the effect on prostate volume and symptoms of shifting to monotherapy in patients who previously received a combination therapy. M...

Descripción completa

Detalles Bibliográficos
Autores principales: Kim, Hyoung Woo, Moon, Dae Geun, Kim, Hyun Min, Hwang, Jong Ho, Kim, Soon Chan, Nam, Sam Geuk, Park, Jun Tag
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Korean Urological Association 2011
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3212662/
https://www.ncbi.nlm.nih.gov/pubmed/22087362
http://dx.doi.org/10.4111/kju.2011.52.10.681

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3212662/
https://www.ncbi.nlm.nih.gov/pubmed/22087362
http://dx.doi.org/10.4111/kju.2011.52.10.681

Ejemplares similares